Abstract
A novel methodology is presented to investigate the organic solvent tolerability of cytochrome P450 monooxygenase BM3 (CYP BM3) mutants. A fluorescence-based continuous-flow enzyme activity detection (EAD) setup was used to screen the activity of CYP BM3 mutants in the presence of organic solvents. The methodology is based on the CYP BM3-mediated O-dealkylation of benzyloxyresorufin to form the highly fluorescent product resorufin. The assay setup not only allows detection of the formed resorufin, but it also simultaneously monitors cofactor depletion online. The EAD setup was used to test the activity of a small library of novel CYP BM3 mutants in flow-injection analysis mode in the presence of the organic modifiers methanol, acetonitrile, and isopropanol. Mutants with enhanced tolerability toward all three solvents were identified, and the EAD setup was adapted to facilitate CYP BM3 activity screening against a gradient of an organic modifier to study the behavior of the small library of CYP BM3 mutants in more detail. The simple methodology used in this study was shown to be a very powerful tool to screen for novel CYP BM3 mutants with increased tolerability toward organic solvents.
Original language | English |
---|---|
Pages (from-to) | 1246-55 |
Number of pages | 10 |
Journal | Journal of Biomolecular Screening |
Volume | 20 |
Issue number | 10 |
DOIs | |
Publication status | Published - Dec 2015 |
Keywords
- Amitriptyline
- Bacterial Proteins
- Cytochrome P-450 Enzyme System
- Enzyme Assays
- Flow Injection Analysis
- Fluorescence
- Mutation
- NADPH-Ferrihemoprotein Reductase
- Solvents
- Journal Article